imidazobenzodiazepines (Uwm Research Foundation)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameimidazobenzodiazepines (Uwm Research Foundation)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-2 agonistsGamma-aminobutyric acid A receptor alpha-3 agonists
TargetsGamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-3
Therapy Area/IndicationsAnxiety DisordersNeuralgiaEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUWM Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUWM Research Foundation Inc
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersNeuralgiaEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A